Ann: Half Yearly Report, page-76

Like SilverFox I'm speechless. Sales of the primary product are also growing. Worldwide. Ok. They aren't growing quite as fast as the market would like, but they are growing. There is solid growth. What the heck? What other company on the ASX right now has solid and consistent international growth in sales? To get a 10% stake, an insto would only have to fork out now 10 Million. To get a controlling 50% stake, a big pharma only 50 Million. This is the maths. That is total peanuts to these guys!!!! Barely buy them a couple new Porsches for the management team. So I ask again? Why aren't our insto's buying this stock on market? When they sit around the table? When the new guy presents the story to the wise old heads? What in their investment philosophy or stock picking formulae or any other investment process they use is stopping them buying this stock on market?